News

AddToAny

Google+ Facebook Twitter Twitter

Label-free histopathology

A research team has developed a machine learning-based label-free histopathology device that can perform histopathology in real time.

It avoids freezing, sectioning, or staining by using the ultraviolet (UV) photoacoustic imaging technology (UV-MEMS PAM) that converges ultra-high-speed MEMS scanner technology.

The researchers proposed a high-speed reflection-mode UV photoacoustic microscopy system using the 1-axis MEMS scanner as a novel label-free intraoperative histopathology method.

They succeeded in visualising label-free cell nuclei of mouse and human tissues using this approach.

In addition, by imaging clinical specimens resected from actual cancer patients and numerically quantifying the histopathological results, the research team successfully demonstrated that the proposed UV-PAM system has great potential as an alternative intraoperative histopathology method.

The device enables 3D imaging without an independent contrast agent and can achieve structural and functional imaging of small cells.

bit.ly/3DqvtDe

Image Credit | Poshtech

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top